Flex Biomedical Raises Nearly $1M to Further Develop Polymer to Treat Osteoarthritis

Flex Biomedical, a privately-held orthopedics company in Boston, has raised $985,000 to advance its lead product, the Flex Polymer, a synthetic polymer to treat osteoarthritis.

Advertisement

The funding includes a $150,000 loan from the state of Wisconsin and investments from several private sources in Wisconsin.

In addition, the company announced it is moving its operations to Madison, Wis.

Read the release about Flex Biomedical.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.